AUTHOR=Tanaka Haku , Nishimura Fumihiko , Nakase Kenta , Yokoyama Shohei , Nakagawa Ichiro , Yamada Shuichi , Tamura Kentaro , Matsuda Ryosuke , Takeshima Yasuhiro , Kotsugi Masashi , Park Young-Soo , Nakase Hiroyuki TITLE=Case report: Giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving COVID-19 vaccination JOURNAL=Frontiers in Surgery VOLUME=10 YEAR=2023 URL=https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2023.1220098 DOI=10.3389/fsurg.2023.1220098 ISSN=2296-875X ABSTRACT=Objective

A case of giant pituitary neuroendocrine tumor presented along with acute visual loss due to pituitary apoplexy after receiving a COVID-19 vaccination is reported.

Case presentation

A 45-year-old man was referred for a giant pituitary tumor with bitemporal hemianopsia. A surgical procedure was planned and then delayed due to the COVID-19 outbreak in Japan, with a Pfizer/BioNTech vaccine administered while awaiting surgery. Three days after the second COVID-19 vaccination the patient noted a progressively worsening headache that caused pituitary apoplexy and then a decrease in vision. Emergency surgery was thus performed.

Conclusion

Pituitary apoplexy is a rare and life-threatening complication that may occur after undergoing a COVID-19 vaccination.